Literature DB >> 3277276

The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation.

M D Sklar1.   

Abstract

Identification of genes that function to protect cells from radiation damage is an essential step in understanding the molecular mechanisms by which mammalian cells cope with ionizing radiation. The intrinsic radiation resistance (D0) of NIH 3T3 cells was markedly and significantly increased by transformation with ras oncogenes activated by missense mutations. This radiobiologic activity appeared to be a specific consequence of the ras mutations rather than of transformation, since revertant cells that contained functional ras genes (but were no longer phenotypically transformed) retained their increased D0's.

Entities:  

Mesh:

Year:  1988        PMID: 3277276     DOI: 10.1126/science.3277276

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  53 in total

1.  Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.

Authors:  H Roelofs; M C Mostert; K Pompe; G Zafarana; M van Oorschot; R J van Gurp; A J Gillis; H Stoop; B Beverloo; J W Oosterhuis; C Bokemeyer; L H Looijenga
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.

Authors:  M D Sklar; E Thompson; M J Welsh; M Liebert; J Harney; H B Grossman; M Smith; E V Prochownik
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  LIN28B confers radio-resistance through the posttranscriptional control of KRAS.

Authors:  Sun-Hye Jeong; Hong-Gyun Wu; Woong-Yang Park
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

4.  Role of transfection and clonal selection in mediating radioresistance.

Authors:  F S Pardo; R G Bristow; A Taghian; A Ong; C Borek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

5.  Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.

Authors:  Pradip De; Yuling Sun; Jennifer H Carlson; Lori S Friedman; Brian R Leyland-Jones; Nandini Dey
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

6.  Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids.

Authors:  Marco Mrusek; Ean-Jeong Seo; Henry Johannes Greten; Michael Simon; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-10-25       Impact factor: 3.850

Review 7.  Altering the response to radiation: sensitizers and protectors.

Authors:  Deborah E Citrin; James B Mitchell
Journal:  Semin Oncol       Date:  2014-10-07       Impact factor: 4.929

8.  Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells.

Authors:  D M O'Rourke; G D Kao; N Singh; B W Park; R J Muschel; C J Wu; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Posttranscriptional down-regulation of ras oncogene expression by inhibitors of cellular glutathione.

Authors:  A C Miller; J Gafner; E P Clark; D Samid
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

10.  Ionizing radiation-induced oxidative stress alters miRNA expression.

Authors:  Nicole L Simone; Benjamin P Soule; David Ly; Anthony D Saleh; Jason E Savage; William Degraff; John Cook; Curtis C Harris; David Gius; James B Mitchell
Journal:  PLoS One       Date:  2009-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.